20' Case-based lecture : Jacqueline Cloos (Amsterdam)
Flow identification and monitoring of leukaemia stem cells
20' Case-based lecture : Emmanuelle Clappier (Paris)
MRD monitoring in Ph-positive ALL
Brief oral communication
5' Circulating microRNAs behaving as minimal residual Dániel János Erdélyi (Budapest)
disease biomarkers in childhood ALL
30' Panel discussion
www.esh.org - info@esh.org 2
95' Routine diagnosis gene expression and mutational profiling
Chair: Oliver Ottmann (Cardiff)
20' Case-based Lecture : Sabina Chiaretti (Rome)
Ph-like ALL diagnosis
20' Case-based lecture : Josep-Maria Ribera (Barcelona)
Minimal / optimal gene panel in ALL ?
20' Case-based lecture : Lars Bullinger (Berlin)
Minimal / optimal gene panel in AML ?
Brief oral communication
5' Integrated whole genome-transcriptome sequencing Georgina Ryland (Melbourne)
compared to conventional diagnostic testing in adult B-ALL
30' Panel discussion
50' DEBATE – All patients with intermediate-risk AML must be transplanted
Chair: Andrew Wei (Melbourne)
15' Yes Charles Craddock (Birmingham)
15' No Gail Roboz (New York)
20' Discussion
30' INTERACTIVE CASES – Mutation-based therapy off-label
Chair: Jorge Sierra (Barcelona)
7' Targeted therapy for Ph-like ALL Sarah Tasian (Philadelphia)
3' Discussion
7' Mutation-based therapy off-label - Nicolas Boissel (Paris)
GO for AML salvage therapy
3' Discussion
7' FLT3 inhibitors post-transplantation Andreas Burchert (Marburg)
3' Discussion